February 22, 2019
Modus announces First Cohort Dosed in U.S. Phase 1 Study of Subcutaneously Administered Sevuparin
Media
February 22, 2019
BONESUPPORT – Publication of a clinical study highlighting Vancomycin release from CERAMENT® V in major hip surgery
February 22, 2019
Oncopeptides Year-end Report 2018
February 21, 2019
Rainier Therapeutics to Participate in the SVB Leerink Global Healthcare Conference
February 20, 2019
BONESUPPORT HOLDING AB (publ) – Invitation to conference call in connection of the Full Year Report 2018
February 19, 2019
Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019
February 19, 2019
Q4 2018 General Market Overview
February 18, 2019
Q4 2018 General Market Overview
February 18, 2019
Oncopeptides will host a webcast in conjunction with its Year-end Report 2018 on 22 February at 14.00 (CET)
February 15, 2019
Rainier Therapeutics Presents Data on Vofatamab in Patients with Advanced Urothelial Cell Carcinoma (Bladder Cancer) Previously Treated with Chemotherapy at ASCO GU 2019
